AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.

AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...

New data from an international study of AliveCor’s smartphone app and accompanying two-wire ECG found the mobile tool to be on par with a standard 12-lead ECG among patients presenting with ST-segment ...

AliveCor has launched (and received FDA clearance for) a new ECG sensor built into an Apple Watch strap, as well as an Apple Watch app on which users can see their ECG in near real-time. The strap, ...

Hot on the heels of a major win for Apple in its patent dispute with fellow wearable device maker AliveCor, the tech giant has hit a roadblock. The U.S. International Trade Commission (ITC) ruled last ...

A potential import ban on the Apple Watch is still on the table as an International Trade Commission (ITC) ruling against the technology cleared presidential review this month. Rulings such as the ...

Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings to detect 35 cardiac determinations, including heart ...

Health technology company AliveCor, maker of connected electrocardiogram devices, is trying to ban U.S. sales of the Apple Watch, claiming the tech giant allegedly infringed on three of its patents.

Apple has been fighting a patent battle with healthtech company AliveCor since last year, as the Cupertino-based company is being accused of infringing patents related to the Apple Watch’s ECG feature ...